114 related articles for article (PubMed ID: 38165777)
1. CRISPR-Cas12a-enhanced mass spectrometric DNA nanomachine for HPV-16 detection in human serum.
Hu Y; Liu L; Wang C; Zhou J; Liu R; Lv Y
Chem Commun (Camb); 2024 Jan; 60(8):976-979. PubMed ID: 38165777
[TBL] [Abstract][Full Text] [Related]
2. Detection of free DNA based on metal-enhanced fluorescence triggered by CRISPR-Cas12a and colorimetric analysis.
Zheng M; Li Y; Zhang L; Li C; Liu M; Tang H
Anal Methods; 2024 May; 16(19):3099-3108. PubMed ID: 38695127
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas12a Powered DNA Framework-Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis.
Su J; Ke Y; Maboyi N; Zhi X; Yan S; Li F; Zhao B; Jia X; Song S; Ding X
Small Methods; 2021 Dec; 5(12):e2100935. PubMed ID: 34928030
[TBL] [Abstract][Full Text] [Related]
4. Sensitive and Amplification-Free Electrochemiluminescence Biosensor for HPV-16 Detection Based on CRISPR/Cas12a and DNA Tetrahedron Nanostructures.
Yu L; Peng Y; Sheng M; Wang Q; Huang J; Yang X
ACS Sens; 2023 Jul; 8(7):2852-2858. PubMed ID: 37402133
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection of HPV16/18 based on a CRISPR-Cas13a/Cas12a dual-channel system.
Zheng X; Li Y; Yuan M; Shen Y; Chen S; Duan G
Anal Methods; 2022 Dec; 14(48):5065-5075. PubMed ID: 36449008
[TBL] [Abstract][Full Text] [Related]
7. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
8. Cas12a/blocker DNA-based multiplex nucleic acid detection system for diagnosis of high-risk human papillomavirus infection.
Han J; Shin J; Lee ES; Cha BS; Kim S; Jang Y; Kim S; Park KS
Biosens Bioelectron; 2023 Jul; 232():115323. PubMed ID: 37079992
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Trans-Cleavage Activity of CRISPR-Cas12a (cpf1) for the Development of a Universal Electrochemical Biosensor.
Dai Y; Somoza RA; Wang L; Welter JF; Li Y; Caplan AI; Liu CC
Angew Chem Int Ed Engl; 2019 Nov; 58(48):17399-17405. PubMed ID: 31568601
[TBL] [Abstract][Full Text] [Related]
10. A novel nanoparticle surface-constrained CRISPR-Cas12a 3D DNA walker-like nanomachines for sensitive and stable miRNAs detection.
Wang X; Mu X; Li J; Liu G; Zhao S; Tian J
Anal Chim Acta; 2023 Apr; 1251():340950. PubMed ID: 36925314
[TBL] [Abstract][Full Text] [Related]
11. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
[No Abstract] [Full Text] [Related]
12. DNA tetrahedron-based CRISPR bioassay for treble-self-amplified and multiplex HPV-DNA detection with elemental tagging.
Zhan X; Zhou J; Jiang Y; An P; Luo B; Lan F; Ying B; Wu Y
Biosens Bioelectron; 2023 Jun; 229():115229. PubMed ID: 36947920
[TBL] [Abstract][Full Text] [Related]
13. The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.
Zhao X; Wu Q; Wang X; Fu Y; Zhang X; Tian X; Cheng B; Lu B; Yu X; Lan S; Lu W; Ma D; Cheng X; Xie X
Clin Microbiol Infect; 2018 Dec; 24(12):1322-1327. PubMed ID: 29518562
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
[No Abstract] [Full Text] [Related]
15. Hydrazone ligation assisted DNAzyme walking nanomachine coupled with CRISPR-Cas12a for lipopolysaccharide analysis.
Wang P; Liu Y; Yu Y; Zhang Y; Peng J; Niu L; Zhang J
Anal Chim Acta; 2021 Aug; 1174():338747. PubMed ID: 34247734
[TBL] [Abstract][Full Text] [Related]
16. [Application of isothermal HPV DNA amplification test in cervical cancer screening].
Wang L; Jiang MY; Qin Y; Li L; Wu ZN; Li TY; Wu T; Chen W
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):313-318. PubMed ID: 29730922
[No Abstract] [Full Text] [Related]
17. Comparison of the clinical performances of the AdvanSure HPV Screening Real-Time PCR, the Abbott Real-Time High-Risk HPV Test, and the Hybrid Capture High-Risk HPV DNA Test for Cervical Cancer Screening.
Chung HS; Hahm C; Lee M
J Virol Methods; 2014 Sep; 205():57-60. PubMed ID: 24814874
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas12a-mediated dual-enzyme cascade amplification for sensitive colorimetric detection of HPV-16 target and ATP.
Gong S; Song K; Zhang S; Zhou P; Pan W; Li N; Tang B
Talanta; 2024 Jan; 266(Pt 2):125050. PubMed ID: 37598442
[TBL] [Abstract][Full Text] [Related]
19. [High-risk HPV genotyping PCR testing as a means of cervical cancer and precancerous lesions early screening].
Ma L; Cong X; Bian M; Shi M; Wang X; Liu J; Liu H
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):246-52. PubMed ID: 26080934
[TBL] [Abstract][Full Text] [Related]
20. Dynamic Aqueous Multiphase Reaction System for One-Pot CRISPR-Cas12a-Based Ultrasensitive and Quantitative Molecular Diagnosis.
Yin K; Ding X; Li Z; Zhao H; Cooper K; Liu C
Anal Chem; 2020 Jun; 92(12):8561-8568. PubMed ID: 32390420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
